CFM
TCRX icon

Catalyst Funds Management’s TScan Therapeutics TCRX Stock Holding History

Catalyst Funds Management’s Portfolio TCRX Stock Details TCRX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$26.1K Buy
+18,000
New +$26.1K 0.01% 411
2024
Q4 		– Sell
-3,200
Closed -$15.9K – 1168
2024
Q3 		$15.9K Buy
+3,200
New +$15.9K ﹤0.01% 1117